Deaths from alcohol-related liver disease in the UK: an escalating tragedy

e-pub ahead of print date: 19 December 2022

Published date: 9 February 2023

Additional Information: Funding Information: We are all members of the Stakeholder Group that reviewed, edited, and commented on the NCEPOD report Remeasuring the Units 2 that is discussed in this Comment; the report is written by the NCEPOD with input from MEDA and JV. JF, GF, IG, and JV were all members of the Standing Lancet Commission on Liver Disease. MEDA reports grants to his institution from GSK and Takeda Research Grant and is the National Services Lead for the British Association for the Study of the Liver (BASL) (unpaid). JV is a member of the Lancet Commission on Liver Disease in Primary Care and a member of the Liver Section of the British Society of Gastroenterology (BSG) and the UK Liver Alliance (unpaid). WB reports consulting fees from Versantis and Flagship Pioneering. MC is the Chair of the British Liver Nurses' Association. JFD is the Vice-President for Hepatology of the BSG. JF reports consulting fees for advisory board from Mirum Pharma. GF reports consulting fees, speaker's fees, or travel fees from Abbvie, BioMarin, UniQure, Gilead, MSD, and GSK and is NHS England Clinical Lead for hepatitis C virus. IG reports medicolegal consultancy for the Medical Defence Union, travel support from the Medical Council on Alcohol, the Alcohol Health Alliance, the Royal College of Physicians, and Royal College of General Practitioners, and is a trustee of the Foundation for Liver Research, the Chair of the Alcohol Health Alliance, and President of the Medical Council on Alcohol (all unpaid). RJ reports accommodation support from the BASL and is President of the BASL. SM is the Clinical Alcohol Lead for the BSG. BO reports support for attending a conference from the BSG, is the National Clinical Lead for Gastroenterology for the NHS England Getting it Right First Time (GIRFT) Programme (NHS England reimburse hospital trust for GIRFT work), and is the Honorary Treasurer of the BSG (unpaid). PR reports grants from National Institute for Health and Care Research's Health Technology Assessment Programme and speaker's fees from Kyowa Kirin. JS is a Trustee of the Society for the Study of Addictions. JW reports travel and accommodation support to attend meetings from the ISICEM and is a member of the Faculty of Intensive Care Medicine Board (unpaid). DW reports grants from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the United Nations Office of Drugs and Crime (UNODC); travel, accommodation, and subsistence costs to attend meetings from the EMCDDA, the UK Advisory Council on the Misuse of Drugs (ACMD), the UNODC, and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT); and is a member of the Scientific Committee of the EAPCCT and the Council of ACMD (unpaid). SC, AD, and VH declare no competing interests.

Local EPrints ID: 484664

URI: http://eprints.soton.ac.uk/id/eprint/484664

DOI: doi:10.1016/S0140-6736(22)02583-1

ISSN: 0140-6736

PURE UUID: 400566a4-a7ec-4fc3-8219-8efb9ddfa4bd

ORCID for Julia Sinclair: orcid.org/0000-0002-1905-2025

Date deposited: 20 Nov 2023 17:35

Last modified: 17 Mar 2024 02:44